Knowledge Center
Patent / Jan 01, 1999
Process for the preparation of purified crystalline iohexol by crystallization using ethanol
Source:
EP 919540
Hydrophobic contaminants (e.g., O-alkylated derivs.) and residual org. solvents are removed from the X-ray contrast agent iohexol by the use of a solvent such as ethanol which the iohexol is insol. one procedure, ethanol is added to aq. soln. of iohexol. another procedure, the iohexol is suspended ethanol and then allowed to crystallize. Cryst. iohexol having a residual solvent content
Also in the Knowledge Center
/ Dec 01, 2015
The importance of human factors in inhaler development: The making of PowdAir®
Read more
Scientific Article
/ Nov 26, 2015
FDA Draft Guidance for Industry: Request for Quality Metrics – FDA-2015-D-2537
Read more
Scientific Article
Scientific Article